KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
Kadota, Kyuichi
KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma. [electronic resource] - The American journal of surgical pathology 12 2016 - 1579-1590 p. digital
Publication Type: Journal Article
1532-0979
10.1097/PAS.0000000000000744 doi
Adenocarcinoma--genetics
Adenocarcinoma of Lung
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor--genetics
DNA Mutational Analysis
ErbB Receptors--genetics
Female
Follow-Up Studies
Humans
Lung Neoplasms--genetics
Male
Middle Aged
Neoplasm Recurrence, Local--genetics
Neoplasm Staging
Pneumonectomy
Prognosis
Proto-Oncogene Proteins p21(ras)--genetics
Retrospective Studies
Survival Analysis
KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma. [electronic resource] - The American journal of surgical pathology 12 2016 - 1579-1590 p. digital
Publication Type: Journal Article
1532-0979
10.1097/PAS.0000000000000744 doi
Adenocarcinoma--genetics
Adenocarcinoma of Lung
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor--genetics
DNA Mutational Analysis
ErbB Receptors--genetics
Female
Follow-Up Studies
Humans
Lung Neoplasms--genetics
Male
Middle Aged
Neoplasm Recurrence, Local--genetics
Neoplasm Staging
Pneumonectomy
Prognosis
Proto-Oncogene Proteins p21(ras)--genetics
Retrospective Studies
Survival Analysis